.no-js-message{position:fixed;top:0;left:0;right:0;background:#222;color:#fff;padding:8px 12px;font-size:14px;z-index:10000;text-align:center}JavaScript is disabled. The site works, but some features may be limited.

INDIA
MONEY
TRAVELLER
EATS
RESPAWN
LUXE

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Delivery within India

Delivery outside India

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Magazine
Markets
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
- Essays
Newsletters
News
AI
Start-Up
Planet
Others
- Spotlight

Budget 2026
Magazine
Markets
OB Datalens
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
- Essays
Newsletters
News
AI
Start-Up
Planet
Tech
Magazine Special Edition
Initiatives
- Spotlight
- C3
About Us

Magazine
Markets
Corporate
Economy & Policy
Newsletters
News
AI
Start-Up
Planet
Others

home
Topic
Drug manufacturer

drug manufacturer

Cipla Profit Down 55.32% at ₹542.51 Crore in Q4

Cipla Profit Down 55.32% at ₹542.51 Crore in Q4

BY PTI

Weight-loss and diabetes drugs displayed at a pharmacy counter in India

Torrent Pharma Captures 38% of India’s Semaglutide Market

BY Outlook Business Desk

History : US President Donald Trump

Economy & Policy

India, China among 23 Countries Listed as Major Drug Transit Nations by US President Trump

BY Outlook Business Desk

Alkem Laboratories : Drug Firm Alkem Laboratories

Alkem Laboratories Q4 Net Profit Rises 6 % to Rs 322 Crore

BY PTI

aurobindo : Aurobindo Pharma

Aurobindo Pharma Q4 Net Dips Marginally to Rs 903 Crore; Revenue at Rs 8,382 Crore

BY PTI

Photo: Getty Images : US President Donald Trump

Trump Inks Order to Bring Down US Drug Prices, But Skips Details on Generics Drugs

BY Vaibhavi Ranjan

Emcure Pharma, 43-Years Old Drugmaker Enters Dalal Street with 31% Premium

Emcure Pharma, 43-Years Old Drugmaker Enters Dalal Street with 31% Premium

BY Outlook Business Desk

Advertisement

Land of Lupin

Land of Lupin

Close Ad

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2026 Outlook Publishing India Pvt Ltd.

Copyright © 2026 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.